Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klauber-DeMore, N.
Right arrow Articles by Van Zee, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klauber-DeMore, N.
Right arrow Articles by Van Zee, K. J.
Related Collections
Right arrow Sentinel lymph node

Annals of Surgical Oncology, Vol 7, Issue 9 636-642, Copyright © 2000 by Society of Surgical Oncology

ARTICLES

Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?

N. Klauber-DeMore, L. K. Tan, L. Liberman, S. Kaptain, J. Fey, P. Borgen, A. Heerdt, L. Montgomery, M. Paglia, J. A. Petrek, H. S. Cody and K. J. Van Zee
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

BACKGROUND: Axillary lymph node status is the strongest prognostic indicator of survival for women with breast cancer. The purpose of this study was to determine the incidence of sentinel node metastases in patients with high-risk ductal carcinoma-in-situ (DCIS) and DCIS with microinvasion (DCISM). METHODS: From November 1997 to November 1999, all patients who underwent sentinel node biopsy for high-risk DCIS (n = 76) or DCISM (n = 31) were enrolled prospectively in our database. Patients with DCIS were considered high risk and were selected for sentinel lymph node biopsy if there was concern that an invasive component would be identified in the specimen obtained during the definitive surgery. Patients underwent intraoperative mapping that used both blue dye and radionuclide. Excised sentinel nodes were serially sectioned and were examined by hematoxylin and eosin and by immunohistochemistry. RESULTS: Of 76 patients with high-risk DCIS, 9 (12%) had positive sentinel nodes; 7 of 9 patients were positive for micrometastases only. Of 31 patients with DCISM, 3 (10%) had positive sentinel nodes. 2 of 3 were positive for micrometastases only. Six of nine patients with DCIS and three of three with DCISM and positive sentinel nodes had completion axillary dissection; one patient with DCIS had an additional positive node detected by conventional histological analysis. CONCLUSIONS: This study documents a high incidence of lymph node micrometastases as detected by sentinel node biopsy in patients with high-risk DCIS and DCISM. Although the biological significance of breast cancer micrometastases remains unclear at this time, these findings suggest that sentinel node biopsy should be considered in patients with high-risk DCIS and DCISM.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
F. J. Dominguez, M. Golshan, D. M. Black, K. S. Hughes, M. A. Gadd, R. Christian, B.-A. Lesnikoski, M. Specht, J. Michaelson, and B. L. Smith
Sentinel Node Biopsy is Important in Mastectomy for Ductal Carcinoma In Situ
Ann. Surg. Oncol., January 1, 2008; 15(1): 268 - 273.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
J. C. Boughey, R. J. Gonzalez, E. Bonner, and H. M. Kuerer
Current Treatment and Clinical Trial Developments for Ductal Carcinoma In Situ of the Breast
Oncologist, November 1, 2007; 12(11): 1276 - 1287.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. H. Moore, K. J. Sweeney, M. E. Wilson, J. I. Goldberg, C. L. Buchanan, L. K. Tan, L. Liberman, R. R. Turner, M. D. Lagios, H. S. Cody III, et al.
Outcomes for Women With Ductal Carcinoma-in-Situ and a Positive Sentinel Node: A Multi-Institutional Audit
Ann. Surg. Oncol., October 1, 2007; 14(10): 2911 - 2917.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
H. S. Cody III
Sentinel Lymph Node Biopsy for DCIS: Are We Approaching Consensus?
Ann. Surg. Oncol., August 1, 2007; 14(8): 2179 - 2181.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
T. B. Julian, S. R. Land, V. Fourchotte, S. R. Haile, E. R. Fisher, E. P. Mamounas, J. P. Costantino, and N. Wolmark
Is Sentinel Node Biopsy Necessary in Conservatively Treated DCIS?
Ann. Surg. Oncol., August 1, 2007; 14(8): 2202 - 2208.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
J.-m. Lee, J. B. Kaplan, M. P. Murray, M. Mazur-Grbec, T. Tadic, D. Stimac, and L. Liberman
Underestimation of DCIS at MRI-Guided Vacuum-Assisted Breast Biopsy
Am. J. Roentgenol., August 1, 2007; 189(2): 468 - 474.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
W. E. Sumner III, L. G. Koniaris, S. E. Snell, S. Spector, J. Powell, E. Avisar, F. Moffat, A. S. Livingstone, and D. Franceschi
Results of 23,810 Cases of Ductal Carcinoma-in-situ
Ann. Surg. Oncol., May 1, 2007; 14(5): 1638 - 1643.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
G. M. Fuhrman
Pro: SLNB in DCIS
Ann. Surg. Oncol., March 1, 2007; 14(3): 1005 - 1006.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
P. Sukumvanich, D. J. Bentrem, H. S. Cody III, E. Brogi, J. V. Fey, P. I. Borgen, and M. L. Gemignani
The Role of Sentinel Lymph Node Biopsy in Paget's Disease of the Breast
Ann. Surg. Oncol., March 1, 2007; 14(3): 1020 - 1023.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
I. J. Bleiweiss, C. S. Nagi, and S. Jaffer
Axillary Sentinel Lymph Nodes Can Be Falsely Positive Due to Iatrogenic Displacement and Transport of Benign Epithelial Cells in Patients With Breast Carcinoma
J. Clin. Oncol., May 1, 2006; 24(13): 2013 - 2018.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. H. Lyman, A. E. Giuliano, M. R. Somerfield, A. B. Benson III, D. C. Bodurka, H. J. Burstein, A. J. Cochran, H. S. Cody III, S. B. Edge, S. Galper, et al.
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
J. Clin. Oncol., October 20, 2005; 23(30): 7703 - 7720.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. M. Kuerer and L. A. Newman
Lymphatic Mapping and Sentinel Lymph Node Biopsy for Breast Cancer: Developments and Resolving Controversies
J. Clin. Oncol., March 10, 2005; 23(8): 1698 - 1705.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. El-Tamer, J. Chun, M. Gill, D. Bassi, S. Lee, H. Hibshoosh, and M. Mansukhani
Incidence and Clinical Significance of Lymph Node Metastasis Detected by Cytokeratin Immunohistochemical Staining in Ductal Carcinoma In Situ
Ann. Surg. Oncol., March 1, 2005; 12(3): 254 - 259.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
E. Brogi, E. Torres-Matundan, L. K. Tan, and H. S. Cody III
The Results of Frozen Section, Touch Preparation, and Cytological Smear Are Comparable for Intraoperative Examination of Sentinel Lymph Nodes: A Study in 133 Breast Cancer Patients
Ann. Surg. Oncol., February 1, 2005; 12(2): 173 - 180.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. E. Mendez, J. V. Fey, H. Cody, P. I. Borgen, and L. M. Sclafani
Can Sentinel Lymph Node Biopsy Be Omitted in Patients With Favorable Breast Cancer Histology?
Ann. Surg. Oncol., January 1, 2005; 12(1): 24 - 28.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
R. J. Gray, B. A. Pockaj, and C. R. Conley
Sentinel Lymph Node Metastases Detected by Immunohistochemistry Only Do Not Mandate Complete Axillary Lymph Node Dissection in Breast Cancer
Ann. Surg. Oncol., December 1, 2004; 11(12): 1056 - 1060.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
H. J. Burstein, K. Polyak, J. S. Wong, S. C. Lester, and C. M. Kaelin
Ductal Carcinoma in Situ of the Breast
N. Engl. J. Med., April 1, 2004; 350(14): 1430 - 1441.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
H. S. Cody III
Sentinel Lymph Node Biopsy for Breast Cancer: Does Anybody Not Need One?
Ann. Surg. Oncol., December 1, 2003; 10(10): 1131 - 1132.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. Intra, S. Zurrida, F. Maffini, A. Sonzogni, G. Trifiro, R. Gennari, P. Arnone, G. Bassani, A. Opazo, G. Paganelli, et al.
Sentinel Lymph Node Metastasis in Microinvasive Breast Cancer
Ann. Surg. Oncol., December 1, 2003; 10(10): 1160 - 1165.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
P. C. Stomper, J. Geradts, S. B. Edge, and E. G. Levine
Mammographic Predictors of the Presence and Size of Invasive Carcinomas Associated With Malignant Microcalcification Lesions Without a Mass
Am. J. Roentgenol., December 1, 2003; 181(6): 1679 - 1684.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
M. Intra, P. Veronesi, G. Mazzarol, V. Galimberti, A. Luini, V. Sacchini, G. Trifiro, O. Gentilini, G. Pruneri, P. Naninato, et al.
Axillary Sentinel Lymph Node Biopsy in Patients With Pure Ductal Carcinoma In Situ of the Breast
Arch Surg, March 1, 2003; 138(3): 309 - 313.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
J. W. Jakub, S. Pendas, and D. S. Reintgen
Current Status of Sentinel Lymph Node Mapping and Biopsy: Facts and Controversies
Oncologist, February 1, 2003; 8(1): 59 - 68.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
P. Tang, S. I. Hajdu, C. C. Conte, and D. A. Filardi
Incidental Finding of Mammary Carcinoma in Lumpectomy Specimens
Ann. Clin. Lab. Sci., January 1, 2003; 33(1): 23 - 31.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
J. Bonnema and C. J. H. van de Velde
Sentinel lymph node biopsy in breast cancer
Ann. Onc., October 1, 2002; 13(10): 1531 - 1537.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
L. Liberman, S. L. Goodstine, D. D. Dershaw, E. A. Morris, L. R. LaTrenta, A. F. Abramson, and K. J. V. Zee
One Operation After Percutaneous Diagnosis of Nonpalpable Breast Cancer: Frequency and Associated Factors
Am. J. Roentgenol., March 1, 2002; 178(3): 673 - 679.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
H. S. Cody III, N. Klauber-DeMore, P. I. Borgen, and K. J. Van Zee
Is It Really Duct Carcinoma In Situ?
Ann. Surg. Oncol., September 1, 2001; 8(8): 617 - 619.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. Dowlatshahi, M. Fan, J. M. Anderson, and K. J. Bloom
Occult Metastases in Sentinel Nodes of 200 Patients With Operable Breast Cancer
Ann. Surg. Oncol., September 1, 2001; 8(8): 675 - 681.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
L. Liberman, C. A. Gougoutas, M. F. Zakowski, L. R. LaTrenta, A. F. Abramson, E. A. Morris, and D. D. Dershaw
Calcifications Highly Suggestive of Malignancy: Comparison of Breast Biopsy Methods
Am. J. Roentgenol., July 1, 2001; 177(1): 165 - 172.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. D. Lagios and M. J. Silverstein
Sentinel Node Biopsy for Patients With DCIS: A Dangerous and Unwarranted Direction
Ann. Surg. Oncol., May 1, 2001; 8(4): 275 - 277.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
P. R. Koduri
Sentinel Lymph Node Micrometastases in DCIS
Ann. Surg. Oncol., May 1, 2001; 8(4): 380 - 380.
[Full Text] [PDF]

Home page
 JCOHome page
R. J. Rosser, A. Giuliano, and K. McMasters
Safety of Sentinel Lymph Node Dissection and Significance of Cytokeratin Micrometastases
J. Clin. Oncol., March 15, 2001; 19(6): 1882 - 1883.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society of Surgical Oncology.